Overview
Healthcare tech platform's Q4 revenue rose 7.4%, beating analyst expectations
Adjusted EBITDA for Q4 beat analyst expectations
Company completed acquisitions of Virsys12 and MissionCare Collective
Outlook
HealthStream projects 2026 revenue between $323 mln and $330 mln
Company expects 2026 net income between $20.4 mln and $22.8 mln
HealthStream anticipates 2026 adjusted EBITDA between $73 mln and $77 mln
Result Drivers
REVENUE GROWTH - Record Q4 revenue driven by a 7.4% increase, primarily from subscription revenue growth
Company press release: ID:nBwbX5Jvza
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Beat
$79.7 mln
$76.20 mln (5 Analysts)
Q4 EPS
$0.09
Q4 Net Income
$2.5 mln
Q4 Adjusted EBITDA
Beat
$18.8 mln
$16.69 mln (5 Analysts)
Q4 Operating Income
$2.4 mln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the software peer group is "buy"
Wall Street's median 12-month price target for HealthStream Inc is $32.50, about 59.7% above its February 20 closing price of $20.35
The stock recently traded at 27 times the next 12-month earnings vs. a P/E of 33 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
